TY - JOUR
T1 - Chorea-acanthocytosis
T2 - Genetic linkage to chromosome 9q21
AU - Rubio, Justin P.
AU - Danek, Adrian
AU - Stone, Caroline
AU - Chalmers, Richard
AU - Wood, Nicholas
AU - Verellen, Christine
AU - Ferrer, Xavier
AU - Malandrini, Alessandro
AU - Fabrizi, Gian M.
AU - Manfredi, Michela
AU - Vance, Jefferey
AU - Pericak-Vance, Margaret
AU - Brown, Robert
AU - Rudolf, Gabrielle
AU - Picard, Fabienne
AU - Alonso, Elisa
AU - Brin, Mitchell
AU - Németh, Andrea H.
AU - Farrall, Martin
AU - Monaco, Anthony P.
N1 - Funding Information:
We would like to thank Dr. Jackie Palace (Radcliffe Infirmary), for reference of CHAC11 II-2, and Dianne McKenna-Yasek (Cecil B. Day Laboratory) and Kamna Das (Duke University Medical Center), for provision of DNA samples. A.H.N. is a Medical Research Council Clinical Scientist Fellow. J.V. and M.P.-V. are supported by National Institute of Neurological Disorders and Stroke grant 1P01 NS-26630. J.P.R. is supported by a Howard Florey Post-Doctoral Fellowship. A.P.M. is a Wellcome Trust Principal Research Fellow. This work was funded by the Wellcome Trust.
PY - 1997/10
Y1 - 1997/10
N2 - Chorea-acanthocytosis (CHAC) is a rare autosomal recessive disorder characterized by progressive neurodegeneration and unusual red-cell morphology (acanthocytosis), with onset in the third to fifth decade of life. Neurological impairment with acanthocytosis (neuroacanthocytosis) also is seen in abetalipoproteinemia and X-linked McLeod syndrome. Whereas the molecular etiology of McLeod syndrome has been defined (Ho et al. 1994), that of CHAC is still unknown. In the absence of cytogenetic rearrangements, we initiated a genomewide scan for linkage in 11 families, segregating for CHAC, who are of diverse geographical origin. We report here that the disease is linked, in all families, to a 6-cM region of chromosome 9q21 that is flanked by the recombinant markers GATA89a11 and D9S1843. A maximum two-point LOD score of 7.1 (Θ = .00) for D9S1867 was achieved, and the linked region has been confirmed by homozygosity-by-descent, in offspring from inbred families. These findings provide strong evidence for the involvement of a single locus for CHAC and are the first step in positional cloning of the disease gene.
AB - Chorea-acanthocytosis (CHAC) is a rare autosomal recessive disorder characterized by progressive neurodegeneration and unusual red-cell morphology (acanthocytosis), with onset in the third to fifth decade of life. Neurological impairment with acanthocytosis (neuroacanthocytosis) also is seen in abetalipoproteinemia and X-linked McLeod syndrome. Whereas the molecular etiology of McLeod syndrome has been defined (Ho et al. 1994), that of CHAC is still unknown. In the absence of cytogenetic rearrangements, we initiated a genomewide scan for linkage in 11 families, segregating for CHAC, who are of diverse geographical origin. We report here that the disease is linked, in all families, to a 6-cM region of chromosome 9q21 that is flanked by the recombinant markers GATA89a11 and D9S1843. A maximum two-point LOD score of 7.1 (Θ = .00) for D9S1867 was achieved, and the linked region has been confirmed by homozygosity-by-descent, in offspring from inbred families. These findings provide strong evidence for the involvement of a single locus for CHAC and are the first step in positional cloning of the disease gene.
UR - http://www.scopus.com/inward/record.url?scp=16944362696&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=16944362696&partnerID=8YFLogxK
U2 - 10.1086/514876
DO - 10.1086/514876
M3 - Article
C2 - 9382101
AN - SCOPUS:16944362696
SN - 0002-9297
VL - 61
SP - 899
EP - 908
JO - American journal of human genetics
JF - American journal of human genetics
IS - 4
ER -